HC Wainwright Brokers Raise Earnings Estimates for Calumet

Calumet, Inc. (NASDAQ:CLMT) – Stock analysts at HC Wainwright lifted their FY2026 earnings estimates for Calumet in a research report issued on Wednesday, September 2nd. HC Wainwright analyst A. Dayal now forecasts that the oil and gas company will post earnings per share of $0.17 for the year, up from their previous forecast of $0.12. HC Wainwright has a “Buy” rating and a $75.00 price objective on the stock. The consensus estimate for Calumet’s current full-year earnings is $0.46 per share. HC Wainwright also issued estimates for Calumet’s FY2027 earnings at $1.11 EPS.

Calumet (NASDAQ:CLMT) last posted its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.12 billion. The business’s revenue for the quarter was up 40.8% on a year-over-year basis. During the same quarter last year, the business earned ($1.70) EPS.

Other equities analysts also recently issued research reports about the company. UBS Group increased their price objective on Calumet from $26.00 to $47.00 and gave the stock a “neutral” rating in a report on Tuesday, August 25th. The Goldman Sachs Group upped their target price on shares of Calumet from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 18th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research note on Friday, August 7th. Citigroup reissued a “buy” rating on shares of Calumet in a research note on Monday, August 10th. Finally, TD Cowen upped their price objective on shares of Calumet from $34.00 to $40.00 and gave the stock a “hold” rating in a report on Wednesday, August 12th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $51.75.

Calumet Stock Up 0.8%

NASDAQ CLMT opened at $53.50 on Friday. Calumet has a twelve month low of $16.56 and a twelve month high of $54.70. The firm has a market capitalization of $4.70 billion, a PE ratio of -34.52 and a beta of 0.72. The stock’s 50 day moving average is $43.40 and its 200 day moving average is $36.09.

Hedge Funds Weigh In On Calumet

Hedge funds have recently bought and sold shares of the company. Fifth Third Bancorp grew its position in Calumet by 11.3% during the 2nd quarter. Fifth Third Bancorp now owns 3,407 shares of the oil and gas company’s stock valued at $123,000 after purchasing an additional 346 shares during the last quarter. Covestor Ltd raised its holdings in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after buying an additional 492 shares during the last quarter. Caldwell Sutter Capital Inc. lifted its stake in shares of Calumet by 2.7% in the second quarter. Caldwell Sutter Capital Inc. now owns 20,000 shares of the oil and gas company’s stock worth $720,000 after buying an additional 517 shares in the last quarter. ProShare Advisors LLC lifted its stake in shares of Calumet by 6.9% in the fourth quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock worth $251,000 after buying an additional 817 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd grew its holdings in shares of Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after buying an additional 1,229 shares during the last quarter. Institutional investors own 34.41% of the company’s stock.

Insider Buying and Selling

In other news, Director Daniel Sajkowski sold 4,240 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the sale, the director directly owned 77,718 shares of the company’s stock, valued at approximately $2,810,282.88. This represents a 5.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.15% of the company’s stock.

Calumet News Summary

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised its price target for Calumet to $75 from $60 and reiterated a “Buy” rating, implying substantial potential upside based on the referenced share price. The firm also increased its 2026 EPS forecasts to $0.62 for the third quarter and $0.24 for the fourth quarter, from $0.60 and $0.22, respectively. HC Wainwright estimates and price target
• Positive Sentiment: Calumet said recent U.S. EPA small-refinery exemptions are expected to reduce its Renewable Identification Number, or RIN, liability by approximately $170 million. The potential savings could improve cash flow and profitability by lowering the company’s renewable-fuel compliance costs. Calumet EPA exemption update
• Positive Sentiment: Calumet’s Montana Renewables business is adjusting its expansion plans to increase sustainable aviation fuel production capacity, with reports indicating a potential target of 200 million gallons annually. Greater SAF capacity could support longer-term growth in renewable fuels. Montana Renewables SAF expansion
• Neutral Sentiment: Calumet plans to participate in the H.C. Wainwright conference, which may provide management an opportunity to discuss operations, the EPA exemptions and its renewable-fuels strategy with investors. Calumet conference announcement
• Neutral Sentiment: Analyst coverage remains mixed overall, with the broader analyst consensus listed as “Hold,” despite H.C. Wainwright’s more bullish outlook.
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. The announcement does not establish wrongdoing, but securities investigations can create legal, reputational and disclosure-related uncertainty. Pomerantz investor investigation

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.